Window of Opportunity in Preserving Laryngeal Function Trial

NCT07423078 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

87

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)
Locally Advanced Laryngeal Squamous Cell Carcinoma
Hypopharyngeal Squamous Cell Carcinoma

Interventions

DRUG: Toripalimab
DRUG: Carboplatin
DRUG: Cisplatin
DRUG: Paclitaxel
RADIATION: Radiation Therapy

Sponsor

Matthew Spector

Collaborators

[object Object]